Observational studyWorld journal of urology2026
The relationship between atherogenic index of plasma and erectile dysfunction: a cross-sectional observational study.
Observational study in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of this study was to investigate whether lipid profiles and atherogenic indices differ between patients with erectile dysfunction (ED) and men without ED.
methodsThis cross-sectional observational study included 142 patients diagnosed with ED and 54 men without ED men serving as the men without ED group. The presence and severity of ED were assessed using the International Index of Erectile Function questionnaire (IIEF-5). The Atherogenic Index of Plasma (AIP) was calculated as the logarithm of the ratio of plasma triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C).
resultsNo significant differences were observed between men with and without erectile dysfunction regarding lipid parameters or atherogenic indices, including AIP. The overall comparison of IIEF-5 scores across AIP categories was not statistically significant, although a modest difference between the lowest and highest AIP groups emerged in an exploratory, unadjusted subgroup analysis. Testosterone levels showed weak but statistically significant inverse correlations with AIP and the TyG index.
conclusionIn this cohort, atherogenic indices, including AIP, were not independently associated with the presence of erectile dysfunction. Exploratory analyses suggest that higher AIP values may reflect an unfavorable metabolic profile rather than a direct marker of ED severity. These findings should be interpreted cautiously and considered hypothesis-generating.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.